New: Introducing “Why Is It Moving?” - lightning-fast, AI-driven explanations of stock moves

Learn More
Last Close
Oct 15  •  04:00PM ET
30.82
Dollar change
+0.84
Percentage change
2.81
%
CategoryUS Equities - Factor & Thematic Asset TypeEquities (Stocks) TagsDeveloped Return% 1Y- Total Holdings35 Perf Week2.03%
SponsorF/m Investments ETF Type Tagsequity Return% 3Y- AUM70.92M Perf Month11.37%
Fund Family Bond Type Tagsinnovation Return% 5Y- NAV/sh Perf Quarter25.18%
Index- Average Maturity Tagshealthcare Return% 10Y 52W High30.42 1.29% Perf Half Y32.04%
Index Weighting Commodity Type Tagsbiotechnology Return% SI 52W Low18.78 64.10% Perf YTD31.75%
Active/Passive Quant Type Tagsmedical Flows% 1M0.57% Volatility0.93% 0.78% Perf Year-
Dividend TTM- ESG Type Tagspharmaceutical Flows% 3M4.14% ATR (14)0.46 Perf 3Y-
Dividend Ex-Date- Dividend Type Sector/Theme Flows% YTD11.47% RSI (14)66.04 Perf 5Y-
Dividend Gr. 3/5Y- - Structure Type Region Flows% 1Y Beta1.41 Perf 10Y-
Expense0.54% Growth/Value SMA203.80% Flows% 3Y Rel Volume0.12 Prev Close29.97
Inverse/Leveraged Market Cap SMA509.13% Flows% 5Y Avg Volume3.04K Price30.82
IPOOct 31, 2024 Option/ShortNo / Yes SMA20023.64% Trades Volume356 Change2.81%
F/m Emerald Life Sciences Innovation ETF seeks long-term capital appreciation. The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund's investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.